Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
960
-
Total 13F shares, excl. options
-
190M
-
Shares change
-
-8.53M
-
Total reported value, excl. options
-
$58.4B
-
Value change
-
-$2.56B
-
Put/Call ratio
-
1.45
-
Number of buys
-
419
-
Number of sells
-
-437
-
Price
-
$306.35
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2015
1,092 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2015.
BIOGEN INC. - Common Stock (BIIB) has 960 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 190M shares
.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), VANGUARD GROUP INC (13.2M shares), FMR LLC (12.9M shares), STATE STREET CORP (9.46M shares), Clearbridge Investments, LLC (8.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.36M shares), BlackRock Institutional Trust Company, N.A. (5.9M shares), WELLINGTON MANAGEMENT GROUP LLP (5.28M shares), BlackRock Fund Advisors (5.16M shares), and JPMORGAN CHASE & CO (4.3M shares).
This table shows the top 960 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.